APA (7th ed.) Citation

Zhao, S., Wu, W., Jiang, H., Ma, L., Pan, C., Jin, C., . . . Wang, K. (2021). Selective Inhibitor of the c-Met Receptor Tyrosine Kinase in Advanced Hepatocellular Carcinoma: No Beneficial Effect With the Use of Tivantinib? Frontiers Media S.A.

Chicago Style (17th ed.) Citation

Zhao, Shankun, Weizhou Wu, Hao Jiang, Lei Ma, Chengyi Pan, Chong Jin, Jinggang Mo, Liezhi Wang, and Kunpeng Wang. Selective Inhibitor of the C-Met Receptor Tyrosine Kinase in Advanced Hepatocellular Carcinoma: No Beneficial Effect With the Use of Tivantinib? Frontiers Media S.A, 2021.

MLA (8th ed.) Citation

Zhao, Shankun, et al. Selective Inhibitor of the C-Met Receptor Tyrosine Kinase in Advanced Hepatocellular Carcinoma: No Beneficial Effect With the Use of Tivantinib? Frontiers Media S.A, 2021.